| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |